BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17156405)

  • 1. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data.
    Lim Z; Pagliuca A; Simpson S; Cottam S; Ervine M; Ho AY; Devereux S; Mufti GJ
    Br J Haematol; 2007 Feb; 136(3):448-50. PubMed ID: 17156405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
    J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit.
    Kew AK; Couban S; Patrick W; Thompson K; White D
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):301-5. PubMed ID: 16503499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation.
    Neumann F; Lobitz O; Fenk R; Bruns I; Köstering M; Steiner S; Hennersdorf M; Kelm M; Strauer BE; Germing U; Hinke A; Haas R; Kobbe G
    Ann Hematol; 2008 Apr; 87(4):299-304. PubMed ID: 18219487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.
    Bokhari SW; Munir T; Memon S; Byrne JL; Russell NH; Beed M
    Ann Hematol; 2010 May; 89(5):505-12. PubMed ID: 19876629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.
    Benoit DD; Hoste EA; Depuydt PO; Offner FC; Lameire NH; Vandewoude KH; Dhondt AW; Noens LA; Decruyenaere JM
    Nephrol Dial Transplant; 2005 Mar; 20(3):552-8. PubMed ID: 15671075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation.
    Kim SW; Kami M; Urahama N; Yamamoto R; Hori A; Imataki O; Kanda Y; Tanosaki R; Mineishi S; Takaue Y; Honda O
    Transplantation; 2003 Feb; 75(4):566-70. PubMed ID: 12605131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in a recent cohort of mechanically ventilated pediatric allogeneic hematopoietic stem cell transplantation recipients.
    van Gestel JP; Bollen CW; Bierings MB; Boelens JJ; Wulffraat NM; van Vught AJ
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1385-93. PubMed ID: 19041061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of percutaneous dilational tracheostomy in hematopoietic stem cell transplantation recipients requiring long-term mechanical ventilation.
    Kluge S; Baumann HJ; Nierhaus A; Kröger N; Meyer A; Kreymann G
    J Crit Care; 2008 Sep; 23(3):394-8. PubMed ID: 18725046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis.
    van Gestel JP; Bollen CW; van der Tweel I; Boelens JJ; van Vught AJ
    Crit Care Med; 2008 Oct; 36(10):2898-904. PubMed ID: 18766109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and utility of scoring systems in patients with hematological malignancies admitted to the intensive care unit and required a mechanical ventilator.
    Nishida K; Palalay MP
    Hawaii Med J; 2008 Oct; 67(10):264-9. PubMed ID: 19097551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure.
    Adda M; Coquet I; Darmon M; Thiery G; Schlemmer B; Azoulay E
    Crit Care Med; 2008 Oct; 36(10):2766-72. PubMed ID: 18766110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation.
    Kache S; Weiss IK; Moore TB
    Pediatr Transplant; 2006 May; 10(3):299-303. PubMed ID: 16677352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant.
    Cheuk DK; Ha SY; Lee SL; Chan GC; Tsoi NS; Lau YL
    Hematol Oncol; 2004 Mar; 22(1):1-9. PubMed ID: 15152366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation.
    Tamburro RF; Barfield RC; Shaffer ML; Rajasekaran S; Woodard P; Morrison RR; Howard SC; Fiser RT; Schmidt JE; Sillos EM
    Pediatr Crit Care Med; 2008 May; 9(3):270-7. PubMed ID: 18446105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid.
    Wanko SO; Broadwater G; Folz RJ; Chao NJ
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):949-53. PubMed ID: 16920561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.